Cargando…
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools
Computational vaccinology includes epitope mapping, antigen selection, and immunogen design using computational tools. Tools that facilitate the in silico prediction of immune response to biothreats, emerging infectious diseases, and cancers can accelerate the design of novel and next generation vac...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154102/ https://www.ncbi.nlm.nih.gov/pubmed/32318055 http://dx.doi.org/10.3389/fimmu.2020.00442 |
_version_ | 1783521765287264256 |
---|---|
author | De Groot, Anne S. Moise, Leonard Terry, Frances Gutierrez, Andres H. Hindocha, Pooja Richard, Guilhem Hoft, Daniel Fredric Ross, Ted M. Noe, Amy R. Takahashi, Yoshimasa Kotraiah, Vinayaka Silk, Sarah E. Nielsen, Carolyn M. Minassian, Angela M. Ashfield, Rebecca Ardito, Matt Draper, Simon J. Martin, William D. |
author_facet | De Groot, Anne S. Moise, Leonard Terry, Frances Gutierrez, Andres H. Hindocha, Pooja Richard, Guilhem Hoft, Daniel Fredric Ross, Ted M. Noe, Amy R. Takahashi, Yoshimasa Kotraiah, Vinayaka Silk, Sarah E. Nielsen, Carolyn M. Minassian, Angela M. Ashfield, Rebecca Ardito, Matt Draper, Simon J. Martin, William D. |
author_sort | De Groot, Anne S. |
collection | PubMed |
description | Computational vaccinology includes epitope mapping, antigen selection, and immunogen design using computational tools. Tools that facilitate the in silico prediction of immune response to biothreats, emerging infectious diseases, and cancers can accelerate the design of novel and next generation vaccines and their delivery to the clinic. Over the past 20 years, vaccinologists, bioinformatics experts, and advanced programmers based in Providence, Rhode Island, USA have advanced the development of an integrated toolkit for vaccine design called iVAX, that is secure and user-accessible by internet. This integrated set of immunoinformatic tools comprises algorithms for scoring and triaging candidate antigens, selecting immunogenic and conserved T cell epitopes, re-engineering or eliminating regulatory T cell epitopes, and re-designing antigens to induce immunogenicity and protection against disease for humans and livestock. Commercial and academic applications of iVAX have included identifying immunogenic T cell epitopes in the development of a T-cell based human multi-epitope Q fever vaccine, designing novel influenza vaccines, identifying cross-conserved T cell epitopes for a malaria vaccine, and analyzing immune responses in clinical vaccine studies. Animal vaccine applications to date have included viral infections of pigs such as swine influenza A, PCV2, and African Swine Fever. “Rapid-Fire” applications for biodefense have included a demonstration project for Lassa Fever and Q fever. As recent infectious disease outbreaks underscore the significance of vaccine-driven preparedness, the integrated set of tools available on the iVAX toolkit stand ready to help vaccine developers deliver genome-derived, epitope-driven vaccines. |
format | Online Article Text |
id | pubmed-7154102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71541022020-04-21 Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools De Groot, Anne S. Moise, Leonard Terry, Frances Gutierrez, Andres H. Hindocha, Pooja Richard, Guilhem Hoft, Daniel Fredric Ross, Ted M. Noe, Amy R. Takahashi, Yoshimasa Kotraiah, Vinayaka Silk, Sarah E. Nielsen, Carolyn M. Minassian, Angela M. Ashfield, Rebecca Ardito, Matt Draper, Simon J. Martin, William D. Front Immunol Immunology Computational vaccinology includes epitope mapping, antigen selection, and immunogen design using computational tools. Tools that facilitate the in silico prediction of immune response to biothreats, emerging infectious diseases, and cancers can accelerate the design of novel and next generation vaccines and their delivery to the clinic. Over the past 20 years, vaccinologists, bioinformatics experts, and advanced programmers based in Providence, Rhode Island, USA have advanced the development of an integrated toolkit for vaccine design called iVAX, that is secure and user-accessible by internet. This integrated set of immunoinformatic tools comprises algorithms for scoring and triaging candidate antigens, selecting immunogenic and conserved T cell epitopes, re-engineering or eliminating regulatory T cell epitopes, and re-designing antigens to induce immunogenicity and protection against disease for humans and livestock. Commercial and academic applications of iVAX have included identifying immunogenic T cell epitopes in the development of a T-cell based human multi-epitope Q fever vaccine, designing novel influenza vaccines, identifying cross-conserved T cell epitopes for a malaria vaccine, and analyzing immune responses in clinical vaccine studies. Animal vaccine applications to date have included viral infections of pigs such as swine influenza A, PCV2, and African Swine Fever. “Rapid-Fire” applications for biodefense have included a demonstration project for Lassa Fever and Q fever. As recent infectious disease outbreaks underscore the significance of vaccine-driven preparedness, the integrated set of tools available on the iVAX toolkit stand ready to help vaccine developers deliver genome-derived, epitope-driven vaccines. Frontiers Media S.A. 2020-04-07 /pmc/articles/PMC7154102/ /pubmed/32318055 http://dx.doi.org/10.3389/fimmu.2020.00442 Text en Copyright © 2020 De Groot, Moise, Terry, Gutierrez, Hindocha, Richard, Hoft, Ross, Noe, Takahashi, Kotraiah, Silk, Nielsen, Minassian, Ashfield, Ardito, Draper and Martin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology De Groot, Anne S. Moise, Leonard Terry, Frances Gutierrez, Andres H. Hindocha, Pooja Richard, Guilhem Hoft, Daniel Fredric Ross, Ted M. Noe, Amy R. Takahashi, Yoshimasa Kotraiah, Vinayaka Silk, Sarah E. Nielsen, Carolyn M. Minassian, Angela M. Ashfield, Rebecca Ardito, Matt Draper, Simon J. Martin, William D. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools |
title | Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools |
title_full | Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools |
title_fullStr | Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools |
title_full_unstemmed | Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools |
title_short | Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools |
title_sort | better epitope discovery, precision immune engineering, and accelerated vaccine design using immunoinformatics tools |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154102/ https://www.ncbi.nlm.nih.gov/pubmed/32318055 http://dx.doi.org/10.3389/fimmu.2020.00442 |
work_keys_str_mv | AT degrootannes betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT moiseleonard betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT terryfrances betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT gutierrezandresh betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT hindochapooja betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT richardguilhem betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT hoftdanielfredric betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT rosstedm betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT noeamyr betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT takahashiyoshimasa betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT kotraiahvinayaka betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT silksarahe betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT nielsencarolynm betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT minassianangelam betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT ashfieldrebecca betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT arditomatt betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT drapersimonj betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools AT martinwilliamd betterepitopediscoveryprecisionimmuneengineeringandacceleratedvaccinedesignusingimmunoinformaticstools |